Cargando…
Signaling in T cells – is anything the m(a)TOR with the picture(s)?
The excitement surrounding checkpoint inhibitors in the treatment of patients with cancer exemplifies a triumph of the long-term value of investing in basic science and fundamental questions of T-cell signaling. The pharmaceutical future actively embraces ways of making more patients’ cancers respon...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
F1000Research
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760271/ https://www.ncbi.nlm.nih.gov/pubmed/26949528 http://dx.doi.org/10.12688/f1000research.7027.1 |